DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Narayanan KR, Bansal D, Walia R et al.
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis.
Pediatr Blood Cancer 2013;
DOI: 10.1002/pbc.24397. [Epub ahead of print]
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.